Annals of Laboratory Medicine

Korean Society for Laboratory Medicine (대한진단검사의학회)
권호 표지
DOI QR코드

DOI QR Code

Molecular and Cytogenetic Studies in a Child with Burkitt Lymphoma and Ataxia-Telangiectasia Syndrome Harboring MYC Overexpression and Partial Trisomy 8

  • De Souza, Mariana T. (Cytogenetics Department, Bone Marrow Transplantation Center, Instituto Nacional de Cancer) ;
  • Vera-Lozada, Gabriela (Post Graduation Oncology Program, Instituto Nacional de Cancer) ;
  • Othman, Moneeb (Institute of Human Genetics, Jena University Hospital, Friedrich Schiller University) ;
  • Marques-Salles, Teresinha J. (Department of Genetics, Pernambuco University) ;
  • Pinto, Luciana W. (Integrated Department of Pathology, Instituto Nacional de Cancer) ;
  • da Rocha, Moises M. (Cytogenetics Department, Bone Marrow Transplantation Center, Instituto Nacional de Cancer) ;
  • Rouxinol, Soraia (Pediatric Hematology Department, Hospital Federal da Lagoa) ;
  • Liehr, Thomas (Institute of Human Genetics, Jena University Hospital, Friedrich Schiller University) ;
  • Ribeiro, Raul C. (Department of Oncology, St. Jude Children's Research Hospital) ;
  • Hassan, Rocio (Post Graduation Oncology Program, Instituto Nacional de Cancer) ;
  • Silva, Maria Luiza M. (Cytogenetics Department, Bone Marrow Transplantation Center, Instituto Nacional de Cancer)
  • Received : 2017.04.19
  • Accepted : 2017.09.11
  • Published : 2018.01.01
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Greenought A and Dave SS. New clues to the molecular pathogenesis of Burkitt lymphoma revealed through next-generation sequencing. Curr Opin Hematol 2014;21:326-32. https://doi.org/10.1097/MOH.0000000000000059
  2. De Souza MT, Hassan R, Liehr T, Marques-Salles TJ, Boulhosa AM, Abdelhay E, et al. Conventional and molecular cytogenetic characterization of Burkitt lymphoma with bone marrow involvement in Brazilian children and adolescents. Pediatr Blood Cancer 2014;61:1422-69. https://doi.org/10.1002/pbc.25030
  3. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016;127:2375-90. https://doi.org/10.1182/blood-2016-01-643569
  4. Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TFE, et al. Molecular mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med 2006;354:2419-30. https://doi.org/10.1056/NEJMoa055351
  5. Onnis A, De Falco G, Antonicelli G, Onorati M, Bellan C, Sherman O, et al. Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma. PloS One 2010;23:909-20.
  6. Leucci E, Cocco M, Onnis A, De Falco G, van Cleef P, Bellan C, et al. MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenic mechanism involving miRNA deregulation. J Pathol 2008;216:440-50. https://doi.org/10.1002/path.2410
  7. Robertus JL, Kluiver J, Weggemans C, Harms G, Reijmers RM, Swart Y, et al. miRNA profiling in B non-Hodgkin lymphoma: a MYC-related miRNA profile characterizes Burkitt lymphoma. Br J Haematol 2010;149:896-9. https://doi.org/10.1111/j.1365-2141.2010.08111.x
  8. Schoenaker MHD, Suarez F, Szczepanski T, Mahlaoui N, Loeffen JL. Treatment of acute leukemia in children with ataxia-telangiectasia (A-T). Eur J Med Genet 2016;59:641-6. https://doi.org/10.1016/j.ejmg.2016.05.012
  9. Sandlund JT, Hudson MM, Kennedy W, Onciu M, Kastan MB. Pilot study of modified LMB-based therapy for children with ataxia-telangiectasia and advanced stage high grade mature b-cell malignancies. Pediatr Blood Cancer 2014;61:360-2. https://doi.org/10.1002/pbc.24696
  10. Vera-Lozada G, Scholl V, Barros MH, Sistic D, Guescinic M, Stocch V, et al. Analysis of biological and technical variability in gene expression assays from formalin-fixed paraffin-embedded classical Hodgkin lymphomas. Exp Mol Pathol 2014;97:433-9. https://doi.org/10.1016/j.yexmp.2014.09.014